Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001291

Drug Information
NameNADH    
SynonymsAdenosine 5'-(trihydrogen pyrophosphate), 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (8CI); AC1L96RW; CHEBI:57945; CID439153; Reduced nicotinamide-adenine dinucleotide; 58-68-4; CHEBI:16908; [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate; NAD-reduced; diphosphopyridine nucleotide reduced; 2fsv; nchembio.150-comp50; DB00157; Diphosphopyridine nucleotide, reduced form; N4505_SIGMA; MolPort-003-958-998; nchembio.94-comp28; NChemBio.2007.9-comp15; Adenosine 5'-(trihydrogen diphosphate), P'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosyl-3-pyridinecarboxamide (9CI); Cozymase I, reduced; NADH+H+; beta-Nicotinamide adenine dinucleotide, reduced dipotassium salt; Nicotinamide adenine dinucleotide, reduced form; nchembio.62-comp9; dihydrodiphosphopyridine nucleotide; CHEMBL1234616; beta-DPNH; nchembio.186-comp5; Coenzyme I, reduced; dihydronicotinamide adenine dinucleotide; beta-NADH; Adenosine pyrophosphate, 5'->5'-ester with 1,4-dihydro-1-beta-D-ribofuranosylnicotinamide (7CI); nchembio.135-comp3; NADH dianion; NADH2; [(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-[[(2R,3S,4R,5R)-5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-phosphinic acid; DPNH; nicotinamide adenine dinucleotide reduced; nchembio.121-comp31; NADH; adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] diphosphate}; bmse000054; Reduced Nicotinamide Adenine Dinucleotide; Nicotinaminde-Adenine-Dinucleotide; [5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[5-(3-carbamoyl-4H-pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate; adenosine 5'-{3-[1-(3-carbamoyl-1,4-dihydropyridin-1-yl)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate}    
IndicationParkinson's diseaseApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassDietary supplement    
CAS NumberCAS 606-68-8
FormularC21H29N7O14P2    
PubChem Compound IDCID 21604869.    
PubChem Substance IDSID 2994.    
ChEBI16908;    
TargetNADH dehydrogenaseBinder[2]
Ref 1Drug information of NADH, 2008 To Reference
Ref 2Mechanism of cadmium-decreased glucuronidation in the rat. Biochem Pharmacol. 1992 Dec 1;44(11):2139-47. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543